ciprofloxacin has been researched along with cyclic gmp in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Borlee, BR; Borlee, GI; Brock, MT; Fedderly, GC; Ferris, RA; Filipowska, LK; Hyatt, DR; Russell, MM | 1 |
| Biavasco, F; Carotti, E; Cedraro, N; Citterio, B; La Teana, A; Mangiaterra, G; Vaiasicca, S | 1 |
| Allcock, HR; Chen, C; Ochetto, A; Siedlecki, CA; Sun, D; Xu, LC | 1 |
1 review(s) available for ciprofloxacin and cyclic gmp
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
3 other study(ies) available for ciprofloxacin and cyclic gmp
| Article | Year |
|---|---|
Pseudomonas aeruginosa variants obtained from veterinary clinical samples reveal a role for cyclic di-GMP in biofilm formation and colony morphology.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Cats; Ciprofloxacin; Cyclic GMP; DNA Gyrase; Dogs; Drug Resistance, Bacterial; Escherichia coli Proteins; Gene Expression; Genome, Bacterial; Gentamicins; Horses; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphoric Diester Hydrolases; Phosphorus-Oxygen Lyases; Pseudomonas aeruginosa | 2017 |
Contribution of Drugs Interfering with Protein and Cell Wall Synthesis to the Persistence of
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; Biofilms; Ceftazidime; Cell Wall; Ciprofloxacin; Cyclic GMP; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Green Fluorescent Proteins; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin; Transformation, Bacterial | 2021 |
Surfaces modified with small molecules that interfere with nucleotide signaling reduce Staphylococcus epidermidis biofilm and increase the efficacy of ciprofloxacin.
Topics: Adenosine Monophosphate; Anti-Bacterial Agents; Biocompatible Materials; Biofilms; Ciprofloxacin; Cyclic GMP; Nucleotides; Staphylococcus epidermidis | 2023 |